Robotic-Assisted Imaging Technologies Market, Analysis and Forecast, 2021-2030 by BIS Research

The surgical medical specialty has matured to deliver in-depth and precise clinical outcomes for both doctors and patients, as well as to enhance surgical workflow patterns in healthcare systems. In comparison to prior eras, the healthcare sector is now integrating more advanced technology that is more informed and connected. The use of robotic-assisted imaging technologies makes diagnosis and surgery safer for patients by making it more precise and minimally invasive.

The global robotic-assisted imaging technologies market products include X-ray, CT, ultrasound, MRI, and others under the imaging modalities segment. It can be further segmented based on mobility and application. It is categorized as stationary and portable segments based on mobility, whereas under the application segment, it is categorized as diagnosis and imaging and treatment.

The Global robotic-assisted imaging technologies market was valued at $617.7 million in 2020 and is projected to reach $2,207.8 million by the end of 2030, growing at a CAGR of 13.74% during the forecast period 2021-2030.

Market Drivers

Presently, the factors driving the growth of the market include rise in minimally invasive surgical procedures across the globe, evolution in image modalities and features, and rise in applications of robotics in the medical field.

Market Challenges

Request Sample Report - Click Here

The challenges that are restricting the growth of the market include robotic failures leading to a low rate of adoption, lack of acceptance of robotic procedures, and safety and privacy concerns related to patient data.

Market Opportunities

Potential opportunities that are likely to boost the growth of the market include increased prevalence for misdiagnosis makes way for robotics in diagnostics and surgery domains high growth opportunities in emerging economies.

Impact of COVID-19

The COVID-19 pandemic had an ambiguous impact on the robotic-assisted imaging technologies market. Few of the imaging modalities, such as X-ray and CT, were used for screening during the COVID-19 pandemic, whereas the majority of the imaging modalities were not used due to postponement of elective surgeries and procedures during the pandemic. In the first half of 2020, the COVID-19 pandemic had a significant influence on elective surgical procedures. On a global scale, the COVID-19 pandemic also significantly impacted regular hospital routine services. During the early stages of the pandemic, hospitals drastically restricted or stopped performing elective surgical procedures to ensure patient safety and to focus on COVID-19 patients.

Market Segmentation

by Imaging Modalities

Under this segmentation, the market is categorized into X-ray, CT, ultrasound, MRI, and others.

The X-ray segment is expected to grow at the highest CAGR of 12.87% during the forecast period 2021-2030.

by Mobility

Under this segmentation, the market is categorized into stationary and portable.

The stationary segment is expected to grow at the highest CAGR of 13.43% during the forecast period 2021-2030.

by Application

Under this segmentation, the market is categorized into diagnosis and imaging and treatment. The diagnosis and imaging segment is expected to grow at the highest CAGR of 13.48% during the forecast period 2021-2030.

by Region

The different regions covered under the market report include North America, Europe, Asia-Pacific, and Rest-of-the-World.

North America dominated the market in 2020 and is anticipated to uphold its dominance throughout the forecast period 2021-2030. The growth in the market is majorly driven by the increasing research and development activities and many companies being located in the U.S.

Key Market Players and Competition Synopsis

Some key players operating in the market include Brainlab AG, Digisens SAS, Epica International, Inc. (Epica Human Health), General Electric Company, Globus Medical, Inc., Medirob AB, Medtronic plc, Neocis, Inc., Novasignal Corporation, Perfint Healthcare, Renishaw plc, Siemens Healthineers AG, Stereotaxis, Inc., and Trivitron Healthcare

The robotic-assisted imaging technologies market has witnessed several strategic and technological developments from January 2017- November 2021, undertaken by different market players to attain their respective market shares in this emerging domain. Some strategies covered in this segment are product development and upgradation, partnerships, collaborations, business expansion, funding activities, regulatory approvals, mergers, and acquisitions. The preferred strategy for companies has been regulatory activities.

Bis Research - Emerging Technology Market Research